Skip to content
by Legal Desire
19 November 2026

Latham & Watkins Advises on Ardent Health’s Secondary Offering

Capital Markets & IPO Expected to close Not stated

Advising firms

Deal team

5 lawyers named
LawyerFirmSeniorityPracticeOffice
Nathan Ajiashvili Lead Latham & Watkins LLP Partner Capital Markets New York
Erika Weinberg Lead Latham & Watkins LLP Partner Capital Markets New York
Lindsey Mills Latham & Watkins LLP Counsel Capital Markets New York
Matthew Dwelle Latham & Watkins LLP Associate Capital Markets Not stated
Renad Alqarni Latham & Watkins LLP Associate Capital Markets Not stated

2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 14.5 (US$14.50 per share)
What the figure measures
Per share
Client
Not stated
Counterparties
Ardent Health, Inc. (Issuer)
Equity Group Investments (Sell-side)
Ventas, Inc. (Sell-side)